SCHEMBL26435233

SCHEMBL26435233

c1ccc(-c2cc(-c3ccccc3)cc(-c3nc(-c4ccc5oc6ccccc6c5c4)nc(-c4cccc5ccc6ccccc6c45)n3)c2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.40
MAPT P10636 5/20 0.40
HPGD P15428 4/20 0.40
ALDH1A1 P00352 4/20 0.40
TSHR P16473 3/20 0.40
HSD17B10 Q99714 3/20 0.40
ALOX15 P16050 1/20 0.40
CASP1 P29466 1/20 0.40
CASP7 P55210 1/20 0.40
ABCG2 Q9UNQ0 6/20 0.40
AHR P35869 2/20 0.40
CYP1A1 P04798 1/20 0.40
CYP1A2 P05177 1/20 0.40
FYN P06241 1/20 0.40
MAPK3 P27361 1/20 0.40
PAX8 Q06710 1/20 0.40
KMT2A Q03164 3/20 0.38
MAPK1 P28482 2/20 0.38
PLA2G2A P14555 2/20 0.38
PLA2G4A P47712 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26435236 0.95 PLA2G2A (0.40) KDM4EMAPTHPGDALDH1A1TSHR
SCHEMBL26435221 0.95 ABCG2 (0.41) KDM4EMAPTHPGDALDH1A1TSHR
SCHEMBL26435234 0.95 ABCG2 (0.41) KDM4EMAPTHPGDALDH1A1TSHR
SCHEMBL26435218 0.94 ABCG2 (0.42) KDM4EMAPTHPGDALDH1A1TSHR
SCHEMBL26435214 0.93 TDP1 (0.37) KDM4EMAPTHPGDALDH1A1TSHR
SCHEMBL26435224 0.92 ABCG2 (0.40) KDM4EMAPTHPGDALDH1A1TSHR
SCHEMBL26435469 0.92 ABCG2 (0.40) KDM4EMAPTHPGDALDH1A1TSHR
SCHEMBL26435272 0.92 TDP1 (0.40) KDM4EMAPTHPGDALDH1A1TSHR
SCHEMBL26435225 0.91 KDM4E (0.40) KDM4EMAPTHPGDALDH1A1TSHR
SCHEMBL23759418 0.91 ABCG2 (0.41) KDM4EMAPTHPGDALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS NOM1, MNS1, NOS1 KDM4E 1841/4885MAPT 2425/4885HPGD 2685/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.